Beta Human Chorionic Gonadotrophin (β-hCG/BHCG)
Clinical Biochemistry
Sample and container requirements
Serum Lithium Heparin Plasma (paediatrics only)
Minimum volume required
Special requirements
None
Patient preparation
Please inform the laboratory if the patient has been treated with monoclonal mouse antibodies or may have received them for diagnostic purposes.
Sample viability
Turnaround time
This assay is run throughout the day and night. The in-lab turnaround time is normally less than 24 hours.
Reference range
β-hCG becomes detectable in maternal blood a few days after implantation. Levels typically rise by at least 63% over 48 hours, although the rate of increase slows as pregnancy advances. Concentrations peak at around 8 – 10 weeks' gestation before declining and plateauing. Ectopic pregnancies may show a slower rise, plateau, or fall in β-hCG concentrations; however, serial β-hCG results alone cannot confirm or exclude an ectopic pregnancy and should be interpreted alongside clinical findings and transvaginal ultrasound.
Clinical guidance
Beta-Human Chorionic Gonadotrophin (βHCG) is produced in the placenta during pregnancy but it can also be produced by tumours of the trophoblast and germ cell tumours. Please refer to LabTestsOnlineUK to learn more about βhCG. https://labtestsonline.org.uk/tests/human-chorionic-gonadotrophin-hcg-test
Notes
Images to go here
This information was last updated on 19 August 2026